CHD7 and CHARGE syndrome: Given that up to 17% of patients with a CHD7 mutation do not fulfil these strict diagnostic criteria [5,8], molecular genetic testing of CHD7 is important to confirm a diagnosis of CHARGE syndrome and enable appropriate health guidance and genetic counselling.